¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"thiosulfate reductase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aldehyde reductase
    ¾Ëµ¥È÷µåȯ¿øÈ¿¼Ò
  • reductase
    ȯ¿øÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reductase
    ȯ¿øÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reductase, 5-alpha-reductase inhibitor
    5a-ȯ¿øÈ¿¼Ò¾ïÁ¦Á¦(¡­ü½êªý£áÈåäð¤ð¥),5a-¸®´öÅ×À̽º¾ïÁ¦Á¦(¡­åäð¤ð¥)
  • NADH-cytochrome b5 reductase
    NADH-½ÃÅäÅ©·Òb5¸®´öŸ¾ÆÁ¦
  • NADH-methemoglobin reductase
    NADH-¸ÞÆ®Çì¸ð±Û·Îºó ȯ¿øÈ¿¼Ò
  • NADPH-dependent methemoglobin reductase
    NADH-ÀÇÁ¸¸ÞÆ®Çì¸ð±Û·Îºó ¸®´öŸ¾ÆÁ¦
  • glutathione reductase
    ±Û·çŸƼ¿Â ¸®´ÚŸÁ¦<ȯ¿øÈ¿¼Ò>.
  • glutathione reductase
    ±Û·çŸƼ¿Â¸®´ÚŸÁ¦<--ȯ¿øÈ¿¼Ò>
  • glutathione reductase deficiency
    ±Û·çŸƼ¿Â ȯ¿øÈ¿¼Ò °áÇÌÁõ.
  • glyoxylate reductase
    ±Û¸®¿Á½Ç»êȯ¿øÈ¿¼Ò.
  • reductase
    ¸®´öŸ¾ÆÁ¦, ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
  • reductase
    ȯ¿øÈ¿¼Ò
  • reductase test
    ȯ¿øÈ¿¼Ò½ÃÇè.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reductase, 5-alpha-reductase inhibitor
    5a-ȯ¿øÈ¿¼Ò¾ïÁ¦Á¦(¡­ü½êªý£áÈåäð¤ð¥),5a-¸®´öÅ×À̽º¾ïÁ¦Á¦(¡­åäð¤ð¥)
  • thiosulfate
  • thiosulfate citrate
    ±¸¿¬»ê¿°Æ¼¿À¼³ÆäÀÌÆ®
  • thiosulfate citrate bile salt
    Ƽ¿À¼³ÆäÀÌÆ®½ÃÀÌÆ®·¹ÀÌÆ®´ãÁó»ê¿°
  • cystine reductase
    ½Ã½ºÆ¾È¯¿øÈ¿¼Ò(¡­ü½êª ý£áÈ).
  • cytochrome b5 reductase deficiency
    ½ÃÅäÅ©·Ò b5 ȯ¿øÈ¿¼Ò °áÇÌ
  • cytochrome reductase
    ½ÃÅäÅ©·Ò ·¹´ÚŸÁ¦<ȯ¿øÈ¿¼Ò(ü½êªý£áÈ)>.
  • dihydropteridine reductase
    Dihydropteridine reductase
  • glutathione reductase
    ±Û·çŸƼ¿Â¸®´ÚŸÁ¦<--ȯ¿øÈ¿¼Ò>
  • glutathione reductase
    ±Û·çŸƼ¿Â ¸®´ÚŸÁ¦<ȯ¿øÈ¿¼Ò>.
  • glutathione reductase deficiency
    ±Û·çŸƼ¿Â ȯ¿øÈ¿¼Ò °áÇÌÁõ.
  • glyoxylate reductase
    ±Û¸®¿Á½Ç»êȯ¿øÈ¿¼Ò.
  • glyoxylic acid reductase deficency
  • reductase
    ȯ¿øÈ¿¼Ò
  • reductase
    ¸®´öŸ¾ÆÁ¦, ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • coenzyme Q-cytochrome c reductase complex
    º¸È¿¼Ò(ÜÍý£áÈ) Q¡¤»çÀÌÅäÅ©·Ò C ¸®´ÚÅ×À̽º (ÔÒ) complex III
  • dihydrofolate reductase
    ÀÌ(ì£)¼ö¼Ò(â©áÈ)Æú»ê(ß«) ¸®´öÅ×À̽º
  • folic acid reductase
    Æú»ê(ß«) ¸®´ÚÅ×À̽º
  • nitrate reductase
    Áú»ê(òòß«) ¸®´ÚÅ×À̽º
  • nitrite reductase
    ¾ÆÁú»ê(ä¬òòß«)¸®´ÚÅ×À̽º
  • reductase
    "¸®´ÚÅ×À̽º, ȯ¿øÈ¿¼Ò(ü½êªý£áÈ)"
  • ribonucleotide reductase
    ¶óÀ̺¸´ºÅ¬¸®¿ÀŸÀÌµå ¸®´ÚÅ×À̽º
  • succinate-coenzyme Q reductase
    ¼÷½Å»ê(ß«)-º¸È¿¼Ò(ÜÍý£áÈ)Q ¸®´ÚÅ×À̽º
  • thioredoxin reductase
    ŸÀÌ¿À·¹µ¶½Å ¸®´öÅ×À̽º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TCBS Thiosulfate Citrate Bile salt Sucrose agar
SAT saliva alcohol test; satellite; serum antitrypsin; single-agent chemotherapy; slide agglutination te...
STS sequence tagged site; serologic test for syphilis; sodium tetradecyl sulfate; sodium thiosulfate; st...
TCBS thiosulfate-citrate-bile salts-sucrose [agar]
TST thiosulfate sulfur-transferase; thromboplastin screening test; total sleep time; transforming sequen...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
STS Sodium thiosulfate
TCBS thiosulfate citrate bile salt sucrose
HMG-CoA reductase 3-Hydroxy-3-methylglutaryl CoA reductase
HMG-CoA reductase 3-Hydroxy-3-methylglutaryl coenzyme A reductase
MTHFR 10-Methylenetetrahydrofolate reductase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acetaldehyde reductase
    ¾Æ¼¼Æ® ¾Ëµ¥ÇÏÀ̵å ȯ¿ø È¿¼Ò
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
thiosulfate reductase <enzyme> In proteus mirabilis; one enzyme catalyses both tetrathionate and thiosulfate reduction
Registry number: EC 1.8.-
(26 Jun 1999)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
gold sodium thiosulfate <chemical> An antirheumatic agent with the same actions and uses as gold sodium thiomalate.
Pharmacological action: antirheumatic agents, gold.
Chemical name: Aurate(3-), bis(monothiosulfato(2-)-O,S)-, trisodium, (T-4)-
(12 Dec 1998)
sodium thiosulfate Na2S2O3-5H2O;an antidote in cyanide poisoning in conjunction with sodium nitrite; used as a prophylactic agent against ringworm infections in swimming pools and baths, and to measure the extracellular fluid volume of the body.
Synonym: sodium hyposulfite.
(05 Mar 2000)
thiosulfate S2O3==;the anion of thiosulfuric acid; elevated in individuals with a molybdenum cofactor deficiency.
(05 Mar 2000)
thiosulfate cyanide transsulfurase <enzyme> An enzyme that catalyses the transfer of the planetary sulfur atom of thiosulfate ion to cyanide ion to form thiocyanate ion.
Chemical name: Thiosulfate:cyanide sulfurtransferase
Registry number: EC 2.8.1.1
(12 Dec 1998)
thiosulfate sulfurtransferase <enzyme> An enzyme that catalyses the transfer of the planetary sulfur atom of thiosulfate ion to cyanide ion to form thiocyanate ion.
Chemical name: Thiosulfate:cyanide sulfurtransferase
Registry number: EC 2.8.1.1
(12 Dec 1998)
thiosulfate thiotransferase <enzyme> An enzyme that catalyses the transfer of the planetary sulfur atom of thiosulfate ion to cyanide ion to form thiocyanate ion.
Chemical name: Thiosulfate:cyanide sulfurtransferase
Registry number: EC 2.8.1.1
(12 Dec 1998)
acetoacetyl-CoA reductase An oxidoreductase catalyzing interconversion of a 3-oxoacyl-CoA and NADPH, and the corresponding d-3-hydroxyacyl-CoA, and NADP+. A step in fatty acid synthesis.
(05 Mar 2000)
acetohexamide reductase <enzyme> Catalyses the conversion of acetohexamide to (-)-hydroxyhexamide
Registry number: EC 1.1.1.-
(26 Jun 1999)
acryloyl-CoA reductase <enzyme> Clostridium kluyveri enzyme; contains fmn, ferredoxin, and flavodoxin; can act as electron donors
Registry number: EC 1.3.99.-
Synonym: acryloyo-coenzyme a reductase
(26 Jun 1999)
aflatoxin B1 aldehyde reductase <enzyme> Catalyses the conversion of the dialdehydic form of aflatoxin b1-dihydrodiol to the dialcohol form
Registry number: EC 1.1.1.-
Synonym: aflatoxin b1-aldehyde reductase, afb1-ar
(26 Jun 1999)
aflatoxin B1 reductase <enzyme> Reduces the cyclopentenone ring of aflatoxin b1 to aflatoxicol; requires NADPH as cofactor
Registry number: EC 1.1.1.-
(26 Jun 1999)
aflatoxin G2a reductase <enzyme> Has broad substrate specificity in cell-free extracts from aspergillus parasiticus; versicolorin a hemiacetal is reduced to versicolorin c; 17-hydroxy-16,17-dihydrosterigmatocystin is reduced to a 14,17-hydrated derivative; aflatoxin g2a is converted to a 13,16-hydrated derivative of afg2
Registry number: EC 1.1.1.-
(26 Jun 1999)
aldehyde reductase <enzyme> An enzyme that catalyses reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses.
Chemical name: Alditol:NAD(P)+ 1-oxidoreductase
Registry number: EC 1.1.1.21
(12 Dec 1998)
aldose reductase A polyol dehydrogenase (NADP+);an oxidoreductase that reversibly converts aldoses to alditols (e.g., glucose to sorbitol) with NADPH as hydrogen donor. An important step in the metabolism of sorbitol and in the formation of diabetic cataracts.
See: d-sorbitol-6-phosphate dehydrogenase.
(05 Mar 2000)
aldose reductase inhibitor <pharmacology> A class of drugs being studied as a way to prevent eye and nerve damage in people with diabetes.
Aldose reductase is an enzyme that is normally present in the eye and in many other parts of the body. It helps change glucose (sugar) into a sugar alcohol called sorbitol. Too much sorbitol trapped in eye and nerve cells can damage these cells, leading to retinopathy and neuropathy.
Drugs that prevent or slow (inhibit) the action of aldose reductase are being studied as a way to prevent or delay these complications of diabetes.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reductase
    ȯ¿øÈ¿¼Ò
  • thiosulfate
    Ƽ¿ÀȲ»ê¿°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á